These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 22168076)
1. [Intestinal dysbiosis in liver cirrhosis]. Zhdanov KV; Gusev DA; Zakharenko SM; Kurtukov MV; Sukachev VS Eksp Klin Gastroenterol; 2011; (6):38-44. PubMed ID: 22168076 [TBL] [Abstract][Full Text] [Related]
2. Small-intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease. Pande C; Kumar A; Sarin SK Aliment Pharmacol Ther; 2009 Jun; 29(12):1273-81. PubMed ID: 19302262 [TBL] [Abstract][Full Text] [Related]
3. [A NEW APPROACH TO TREATMENT LIVER CIRRHOSIS IN CONNECTION WITH INTESTINAL DYSBIOSIS]. Gavrysh IM; Glushko LV Lik Sprava; 2014; (9-10):70-6. PubMed ID: 26492779 [TBL] [Abstract][Full Text] [Related]
4. [Cirrhosis of the liver and small intestine. Clinical, biological, histological, immunological and bacteriological comparisons]. Cornet A; Hartmann L; Courtois JE; Dubrisay J; Demelier JF; Barbier JP; Renault P; Carnot F; Debetz J; Dadoune JP Sem Hop; 1973 May; 49(23):1639-48. PubMed ID: 4356216 [No Abstract] [Full Text] [Related]
5. Persistent, fulminant watery diarrhea complicating chronic active hepatitis. Keusch GT; Kaplan MM; Smith D; Ravanesi P Gastroenterology; 1972 Feb; 62(2):307-13. PubMed ID: 4637989 [No Abstract] [Full Text] [Related]
6. [Impairment of intestinal mucosa composition in mechanisms of intestinal dysfunction development in patients with hepatic cirrhosis]. Ter Arkh; 2012; 84(2):41-5. PubMed ID: 22715661 [TBL] [Abstract][Full Text] [Related]
7. Quantification of superparamagnetic iron oxide-mediated signal intensity change in patients with liver cirrhosis using T2 and T2* mapping: a preliminary report. Chung YE; Park MS; Kim MS; Kim E; Park J; Song HT; Choi JY; Kim MJ; Kim KW J Magn Reson Imaging; 2010 Jun; 31(6):1379-86. PubMed ID: 20512890 [TBL] [Abstract][Full Text] [Related]
8. [Disorders of gut microflora in the pathogenesis of liver cirrhosis and complications of portal hypertension]. Anikina EV; Kovtun AV; Iakovenko AV; Gioeva IZ; Iakovenko ÉP; Agafonova NA; Ivanov AN; Volosheĭnikova TV; Grigor'eva IuV Eksp Klin Gastroenterol; 2014; (12):20-3. PubMed ID: 26058107 [TBL] [Abstract][Full Text] [Related]
9. [Intestinal repercussion of biliary diseases and vice versa]. Martinez Marquez M Prensa Med Argent; 1969 Oct; 56(34):1647-51. PubMed ID: 5405576 [No Abstract] [Full Text] [Related]
10. Sorafenib in unresectable hepatocellular carcinoma from mild to advanced stage liver cirrhosis. Pinter M; Sieghart W; Graziadei I; Vogel W; Maieron A; Königsberg R; Weissmann A; Kornek G; Plank C; Peck-Radosavljevic M Oncologist; 2009 Jan; 14(1):70-6. PubMed ID: 19144684 [TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis. Wörns MA; Weinmann A; Pfingst K; Schulte-Sasse C; Messow CM; Schulze-Bergkamen H; Teufel A; Schuchmann M; Kanzler S; Düber C; Otto G; Galle PR J Clin Gastroenterol; 2009; 43(5):489-95. PubMed ID: 19247201 [TBL] [Abstract][Full Text] [Related]
12. Long-Term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function. Madrid AM; Hurtado C; Venegas M; Cumsille F; Defilippi C Am J Gastroenterol; 2001 Apr; 96(4):1251-5. PubMed ID: 11316178 [TBL] [Abstract][Full Text] [Related]
13. Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension. Gunnarsdottir SA; Sadik R; Shev S; Simrén M; Sjövall H; Stotzer PO; Abrahamsson H; Olsson R; Björnsson ES Am J Gastroenterol; 2003 Jun; 98(6):1362-70. PubMed ID: 12818282 [TBL] [Abstract][Full Text] [Related]
15. Early and late outcome of cardiac surgery in patients with liver cirrhosis. Filsoufi F; Salzberg SP; Rahmanian PB; Schiano TD; Elsiesy H; Squire A; Adams DH Liver Transpl; 2007 Jul; 13(7):990-5. PubMed ID: 17427174 [TBL] [Abstract][Full Text] [Related]
16. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts. Koruk M; Onuk MD; Akçay F; Savas MC Hepatogastroenterology; 2002; 49(48):1645-8. PubMed ID: 12397754 [TBL] [Abstract][Full Text] [Related]
17. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C. Dinesen L; Caspary WF; Chapman RW; Dietrich CF; Sarrazin C; Braden B Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592 [TBL] [Abstract][Full Text] [Related]